Diagnostics can play a role in stewardship throughout the pandemic by facilitating a quick diagnosis of COVID-19 and identifying if there is also a bacterial co-infection.
In the past, the development of antimicrobial stewardship efforts mainly focused on prescribers and pharmacists. Today, as the threat of AMR increases, there is growing recognition of the need for efforts to also focus on other stakeholders in antibiotic use—particularly nurses
Whole genome sequencing (WGS), the process of determining the complete nucleotide or DNA/RNA sequence of a genome at one time, has made headlines recently for its potential to transform infectious disease management, particularly related to SARS-CoV-2, the virus responsible for the COVID-19 pandemic.
The COVID-19 pandemic poses a threat to our antibiotic infrastructure, which is already compromised due to a lack of new therapies. That threat makes antimicrobial stewardship even more important.